» Articles » PMID: 39711818

Outcome of Down Patients with Repaired Versus Unrepaired Atrioventricular Septal Defect

Overview
Date 2024 Dec 23
PMID 39711818
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Patients with Down Syndrome (DS) are frequently born with an atrioventricular septal defect (AVSD). Surgical repair of the defect aims to minimize mortality and morbidity. However, a surgical intervention, specifically in DS patients, is not without risk and a subgroup of patients underwent only conservative non-surgical treatment. Outcome data of these different approaches are scarce. The aim of this retrospective study was to compare the long-term outcome of DS patients with and without surgery for AVSD.

Methods: DS patients registered with AVSD in the hospital's database from January 1980 till December 2020 were selected. Patient characteristics, peri-operative if appropriate, and follow-up data were obtained from the medical files.

Results: In total, 72 unrepaired (36 male, 50%) and 134 repaired patients (61 male, 46%) were included. After a maximum of 60 years of follow-up, the all-cause mortality was 45.8% and 17.1%, respectively. Thirty-six percent and 13%, respectively, were labeled as non-cardiovascular death. Mean survival time for unrepaired AVSD was 40.7 years (95% CI 36.1-45.2) and for repaired AVSD 38.5 years (95% CI 35.3-41.6) (Log rank p = 0.465). However, the survival rate 35 years after birth was 62.1% for unrepaired patients versus 81.7% for repaired patients. Mortality rates were the highest the first months after surgical repair.

Conclusions: The mean survival rate of Down patients, born with an AVSD, did not differ between repair or not. However, long-term survival rate was higher in patients who underwent surgical repair. Mortality was highest the first months after surgery.

References
1.
Ramphul K, Mejias S, Joynauth J . Down syndrome predisposes to congenital cardiac malformations. EXCLI J. 2019; 18:799-800. PMC: 6806134. DOI: 10.17179/excli2019-1783. View

2.
Xie O, Brizard C, dUdekem Y, Galati J, Kelly A, Yong M . Outcomes of repair of complete atrioventricular septal defect in the current era. Eur J Cardiothorac Surg. 2013; 45(4):610-7. DOI: 10.1093/ejcts/ezt444. View

3.
Alexander M, Petri H, Ding Y, Wandel C, Khwaja O, Foskett N . Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol. 2015; 58(3):246-54. DOI: 10.1111/dmcn.12868. View

4.
Yang Q, Rasmussen S, Friedman J . Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002; 359(9311):1019-25. DOI: 10.1016/s0140-6736(02)08092-3. View

5.
Asim A, Kumar A, Muthuswamy S, Jain S, Agarwal S . "Down syndrome: an insight of the disease". J Biomed Sci. 2015; 22:41. PMC: 4464633. DOI: 10.1186/s12929-015-0138-y. View